A novel hypoglycemic agent: polysaccharides from laver (Porphyra spp.). Issue 10 (6th October 2020)

• Record Type: Journal Article
• Authors: Zeng, Aoqiong; Yang, Ruijin; Yu, Shuhuai; Zhao, Wei
• Is Part Of: Food & function. Volume 11:Issue 10(2020)
• Page Start: 9048
• Page End: 9056
• Publication Date: 2020-10-06
• Subjects: Food -- Analysis -- Periodicals; Food -- Composition -- Periodicals; Nutrition -- Periodicals; 664.07
• DOI: 10.1039/d0fo01195a
• Languages: English
• ISSNs: 2042-6496

Abstract

Abstract : The laver crude polysaccharides were extracted, purified, and subsequently degraded using H2 O2 . One low-molecular-weight polysaccharide PD-1 showing the highest inhibition activity against α-amylase might be used as a novel agent for T2DM management. Abstract : Type-II diabetes mellitus (T2DM) has become one of the most prevalent diseases on Earth and some treatments have been developed to manage it. One intestinal enzyme α-amylase can break down starch to glucose. Inhibiting its activity will control blood glucose and provide an essential approach for the management of T2DM. Alpha-amylase inhibitor (α-AI) specifically inhibits the activity of α-amylase, and reduces the blood glucose level efficiently. To develop a novel α-AI, the red seaweed laver ( Porphyra spp.) was exploited in this work, whose extracts contain polysaccharides showing an inhibitory effect against α-amylase. The crude polysaccharides were extracted using hot water (85 °C) and degraded to low-molecular-weight polysaccharides with 7% of H2 O2 . One polysaccharide PD-1 exhibiting a competitive binding mode with an IC50 of 12.72 mg mL −1 was separated from these degraded polysaccharides, showing approximately 98.78% of α-amylase inhibition activity. In vivo, PD-1 could efficiently suppress postprandial blood glucose levels in normal and diabetic rats. The polysaccharide inhibitor from red seaweed laver could be regarded as a novel functional food ingredient in T2DM management.